These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
529 related items for PubMed ID: 9023264
21. Comparison of the in vitro receptor binding properties of N-[3H]methylspiperone and [3H]raclopride to rat and human brain membranes. Hall H, Wedel I, Halldin C, Kopp J, Farde L. J Neurochem; 1990 Dec; 55(6):2048-57. PubMed ID: 1977888 [Abstract] [Full Text] [Related]
22. [The affinities of mosapramine for the dopamine receptor subtypes in human cell lines expressing D2, D3 and D4 receptors]. Futamura T, Ohashi Y, Yano K, Takahashi Y, Haga K, Fukuda T. Nihon Yakurigaku Zasshi; 1996 May; 107(5):247-53. PubMed ID: 8690306 [Abstract] [Full Text] [Related]
23. II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1. Primus RJ, Thurkauf A, Xu J, Yevich E, McInerney S, Shaw K, Tallman JF, Gallagher DW. J Pharmacol Exp Ther; 1997 Aug; 282(2):1020-7. PubMed ID: 9262371 [Abstract] [Full Text] [Related]
24. Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2. Niznik HB, Grigoriadis DE, Pri-Bar I, Buchman O, Seeman P. Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):333-43. PubMed ID: 2863760 [Abstract] [Full Text] [Related]
25. Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brain. Andersen PH. Eur J Pharmacol; 1988 Jan 27; 146(1):113-20. PubMed ID: 2895008 [Abstract] [Full Text] [Related]
26. Effects of chronic treatment with typical and atypical antipsychotic drugs on the rat striatum. Lee H, Tarazi FI, Chakos M, Wu H, Redmond M, Alvir JM, Kinon BJ, Bilder R, Creese I, Lieberman JA. Life Sci; 1999 Jan 27; 64(18):1595-602. PubMed ID: 10328519 [Abstract] [Full Text] [Related]
27. Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs. Fitzgerald LW, Deutch AY, Gasic G, Heinemann SF, Nestler EJ. J Neurosci; 1995 Mar 27; 15(3 Pt 2):2453-61. PubMed ID: 7891180 [Abstract] [Full Text] [Related]
28. Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors. Malmberg A, Jackson DM, Eriksson A, Mohell N. Mol Pharmacol; 1993 May 27; 43(5):749-54. PubMed ID: 8099194 [Abstract] [Full Text] [Related]
29. High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors. Kessler RM, Ansari MS, Schmidt DE, de Paulis T, Clanton JA, Innis R, al-Tikriti M, Manning RG, Gillespie D. Life Sci; 1991 May 27; 49(8):617-28. PubMed ID: 1830917 [Abstract] [Full Text] [Related]
30. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats. Rupniak NM, Kilpatrick G, Hall MD, Jenner P, Marsden CD. Psychopharmacology (Berl); 1984 May 27; 84(4):512-9. PubMed ID: 6441952 [Abstract] [Full Text] [Related]
31. Long-term treatment with haloperidol or clozapine does not affect dopamine D4 receptors in rat frontal cortex. Kusumi I, Ishikane T, Matsubara S, Koyama T. J Neural Transm Gen Sect; 1995 May 27; 101(1-3):231-5. PubMed ID: 8695053 [Abstract] [Full Text] [Related]
32. Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine. Seeman P, Tallerico T. Am J Psychiatry; 1999 Jun 27; 156(6):876-84. PubMed ID: 10360126 [Abstract] [Full Text] [Related]
33. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat. Rupniak NM, Hall MD, Mann S, Fleminger S, Kilpatrick G, Jenner P, Marsden CD. Biochem Pharmacol; 1985 Aug 01; 34(15):2755-63. PubMed ID: 4040370 [Abstract] [Full Text] [Related]
34. 2-aminotetralin-derived substituted benzamides with mixed dopamine D2, D3, and serotonin 5-HT1A receptor binding properties: a novel class of potential atypical antipsychotic agents. Homan EJ, Copinga S, Elfström L, van der Veen T, Hallema JP, Mohell N, Unelius L, Johansson R, Wikström HV, Grol CJ. Bioorg Med Chem; 1998 Nov 01; 6(11):2111-26. PubMed ID: 9881101 [Abstract] [Full Text] [Related]
35. [3H]nemonapride and [3H]spiperone label equivalent numbers of D2 and D3 dopamine receptors in a range of tissues and under different conditions. Vile JM, D'Souza UM, Strange PG. J Neurochem; 1995 Feb 01; 64(2):940-3. PubMed ID: 7830089 [Abstract] [Full Text] [Related]
37. In vivo labelling of rat brain dopamine D-2 receptors. Stereoselective blockade by the D-2 antagonist raclopride and its enantiomer of 3H-spiperone, 3H-N,N-propylnorapomorphine and 3H-raclopride binding in the rat brain. Köhler C, Karlsson-Boethius G. J Neural Transm; 1988 Feb 01; 73(2):87-100. PubMed ID: 2974879 [Abstract] [Full Text] [Related]
38. D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: influence of withdrawal period. Joyce JN. Synapse; 2001 May 01; 40(2):137-44. PubMed ID: 11252025 [Abstract] [Full Text] [Related]
39. Are striatal dopamine D4 receptors increased in schizophrenia? Reynolds GP, Mason SL. J Neurochem; 1994 Oct 01; 63(4):1576-7. PubMed ID: 7931313 [Abstract] [Full Text] [Related]
40. Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata. Seeman P, Guan HC, Van Tol HH, Niznik HB. Synapse; 1993 Aug 01; 14(4):247-53. PubMed ID: 8248849 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]